Back to top
more

CareDx (CDNA)

(Delayed Data from NSDQ)

$7.56 USD

7.56
492,533

0.00 (0.00%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $7.54 -0.02 (-0.26%) 4:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 252)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

CareDx (CDNA) in Focus: Stock Moves 9.8% Higher

by Zacks Equity Research

CareDx (CDNA) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

CareDx Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research

CareDx has been struggling lately, but the selling pressure may be coming to an end soon.

Sweta Killa headshot

Best Sector of 2018 and its Hit ETFs & Stocks

by Sweta Killa

Healthcare was the best-performing sector of 2018 and we have highlighted top-performing ETFs and stocks from this sector.

CareDx (CDNA) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

CareDx (CDNA) delivered earnings and revenue surprises of 50.00% and 14.70%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

CareDx (CDNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should Invesco DWA SmallCap Momentum ETF (DWAS) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for DWAS

    Should Invesco DWA SmallCap Momentum ETF (DWAS) Be on Your Investing Radar?

    by Zacks Equity Research

    Style Box ETF report for DWAS

      Teladoc (TDOC) Hits 52-Week High, Will the Rally Continue?

      by Zacks Equity Research

      Strong second-quarter earnings performance and favorable guidance pulled up the stock of Teladoc (TDOC).

        CareDx (CDNA) Reports Q2 Loss, Tops Revenue Estimates

        by Zacks Equity Research

        CareDx (CDNA) delivered earnings and revenue surprises of 20.00% and 16.49%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

          Here's Why You Should Steer Clear of LifePoint (LPNT) Stock

          by Zacks Equity Research

          LifePoint (LPNT) continues to suffer due to a challenging volume environment and weak revenues.

            The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy

            by Zacks Equity Research

            The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy

              4 Attractive Stocks to Buy in an Evolving Healthcare Space

              by Zacks Equity Research

              The evolving healthcare industry presents an attractive buying opportunity for investors.

                The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx

                by Zacks Equity Research

                The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx

                  4 Top-Ranked Growth Stocks in MedTech Under $20

                  by Zacks Equity Research

                  In the wake of the turbulent political scenario and banking on favorable metrics, these four MedTech stocks stand out as the most suitable picks.

                    Teladoc Rides on Growing Demand for Telehealth Services

                    by Zacks Equity Research

                    Rising demand for telehealth services is likely to create long-term growth opportunities for Teladoc's (TDOC).

                      Low Waste Revenues to Hurt Stericycle's (SRCL) Q3 Earnings?

                      by Zacks Equity Research

                      Stericycle (SRCL) is likely to record lower revenues from Regulated Waste and Compliance Services segment due to aggressive pricing by competitors to gain market share, resulting in lower earnings for the quarter.

                        Will Tinder & PMC Growth Aid Match Group (MTCH) Q3 Earnings?

                        by Zacks Equity Research

                        Match Group's (MTCH) third-quarter 2017 earnings results to benefit from steady market traction of apps like Tinder, which are driving higher PMC (paid-member count).

                          PAREXEL's Acquisition by Pamplona Approved by Shareholders

                          by Zacks Equity Research

                          The long-awaited PAREXEL (PRXL) acquisition by Pamplona Capital Management finally receives shareholders' approval. Moreover, the company plans to go private post-acquisition.

                            Land on 5 Winning Stocks with the Ignored Rising P/E Trick

                            by Zacks Equity Research

                            Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

                              What's in the Cards for Box, Inc (BOX) in Q1 Earnings?

                              by Zacks Equity Research

                              Box, Inc. (BOX) is set to report first-quarter fiscal 2018 results on May 31. Last quarter, the company delivered a positive earnings surprise of 6.67%.

                                Intuit (INTU) to Report Q3 Earnings: Will it Disappoint?

                                by Zacks Equity Research

                                Intuit Inc. (INTU) is set to report third-quarter 2017 results on May 23.

                                  Can FactSet Research (FDS) Pull a Surprise in Q2 Earnings?

                                  by Zacks Equity Research

                                  FactSet Research Systems Inc. (FDS) is set to report second-quarter fiscal 2017 results on Mar 28.